Related Experiment Video
Updated: Jun 28, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
[Apoptosis of human keloid fibroblast induced by small interfering RNA-mediated CyclinD1 gene silencing]
Da-Ning Liang1, Jian-Hua Gao, Feng Lu
1Department of Plastic Surgery, Nanfang Hospital of the Southern Medical University, Guangzhou 510515, China.
Objective:
To study the inhibition effect of CyclinD1 specific small interfering RNA(siRNA) on CyclinD1 gene expression in human keloid fibroblast, investigating the effect of CyclinD1 specific siRNA (siRNA-CyclinD1) on the cell cycle, multiplication and apoptosis.
Methods:
According to the principle of siRNA design, siRNA-CyclinD1 was designed and the keloid fibroblast were transfected. RT-PCR was used to examine CyclinD1 mRNA expression. Flow cytometry was used to examine cell cycle. The apoptotic rate was analyzed by using Annexin V-FITC/PI kit. The DNA gragmentation were measured by DNA ladder analysis.
Results:
After transfection, the expression of CyclinD1 mRNA decreased remarkably. Twenty-four, forty-eight and seventy-two hours after transfection, the radio of G1 stage cell was (59.80 +/- 3.06)%, (66.01 +/- 4.03)% and (67.43 +/- 5.35)%, all significantly higher than in the control group (54.50 +/- 5.35)%; the radio of S stage cell was (18.40 +/- 1.42)%, (17.21 +/- 1.76)% and (11.07 +/- 1.00)%, significantly lower than in the control group (22.33 +/- 1.49)%; the proportion of the cells in G1 stage increased and those in the S stage decreased in the keloid fibroblast transfected with siRNA-CyclinD1. The apoptotic rate of the siRNA-CyclinD1 group was (7.82 +/- 0.45)%, (15.71 +/- 1.06)%, (18.32 +/- 1.08)%, all significantly higher than in the control group (0.68 +/- 0.12)%, and the DNA gragmentation can be seen remarkably.
Conclusions:
Chemically synthesized siRNA- CyclinD1 effectively inhibits. The expression of CyclinD1 in keloid fibroblast thus arresting the cell cycle at G1 stage and enhancing cell apoptosis. Our study provided a preliminary results in seaching of a RNAi therapy of keloid.
Insights
Small interfering RNA targeting CyclinD1 (siRNA-CyclinD1) effectively inhibits CyclinD1 gene expression in human keloid fibroblasts. This inhibition leads to cell cycle arrest at the G1 stage and increased apoptosis, suggesting potential RNAi therapy for keloids.
Area of Science:
- Molecular Biology
- Cell Biology
- Dermatology
Context:
- Keloids are characterized by excessive fibroblast proliferation.
- CyclinD1 is a key regulator of cell cycle progression.
- Targeting CyclinD1 offers a potential therapeutic strategy for keloid treatment.
Purpose:
- To investigate the inhibitory effect of CyclinD1-specific small interfering RNA (siRNA-CyclinD1) on CyclinD1 gene expression in human keloid fibroblasts.
- To evaluate the impact of siRNA-CyclinD1 on keloid fibroblast cell cycle, proliferation, and apoptosis.
Summary:
- siRNA-CyclinD1 was designed and transfected into human keloid fibroblasts.
- RT-PCR confirmed significant downregulation of CyclinD1 mRNA expression.
- Flow cytometry revealed G1 cell cycle arrest and increased apoptotic rates, with DNA fragmentation observed.
Impact:
- siRNA-CyclinD1 effectively inhibits CyclinD1 expression in keloid fibroblasts.
- This inhibition arrests the cell cycle at G1 and enhances apoptosis.
- The findings provide preliminary evidence for RNAi-based therapy for keloids.
Related Concept Videos
Experimental RNAi
The Extrinsic Apoptotic Pathway
Inhibition of Cdk Activity
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle
